Attached files

file filename
10-K - 10-K - HUMAN GENOME SCIENCES INCw81670e10vk.htm
EX-10.2 - EX-10.2 - HUMAN GENOME SCIENCES INCw81670exv10w2.htm
EX-32.2 - EX-32.2 - HUMAN GENOME SCIENCES INCw81670exv32w2.htm
EX-31.1 - EX-31.1 - HUMAN GENOME SCIENCES INCw81670exv31w1.htm
EX-12.1 - EX-12.1 - HUMAN GENOME SCIENCES INCw81670exv12w1.htm
EX-32.1 - EX-32.1 - HUMAN GENOME SCIENCES INCw81670exv32w1.htm
EX-10.3 - EX-10.3 - HUMAN GENOME SCIENCES INCw81670exv10w3.htm
EX-31.2 - EX-31.2 - HUMAN GENOME SCIENCES INCw81670exv31w2.htm
EX-21.1 - EX-21.1 - HUMAN GENOME SCIENCES INCw81670exv21w1.htm
EXHIBIT 23.1
CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements:
  (1)   Registration Statement (Form S-3 No. 333-121724) of Human Genome Sciences, Inc.,
 
  (2)   Registration Statement (Form S-3 No. 333-128874) of Human Genome Sciences, Inc.,
 
  (3)   Registration Statement (Form S-3 No. 333-162731) of Human Genome Sciences, Inc.,
 
  (4)   Registration Statement (Form S-8 No. 333-44798) of Human Genome Sciences, Inc. 2000 Stock Incentive Plan and Human Genome Sciences, Inc. Employee Stock Purchase Plan,
 
  (5)   Registration Statement (Form S-8 No. 333-66670) of Human Genome Sciences, Inc. Amended and Restated 2000 Stock Incentive Plan,
 
  (6)   Registration Statement (Form S-8 No. 333-89392) of Human Genome Sciences, Inc. Amended and Restated 2000 Stock Incentive Plan,
 
  (7)   Registration Statement (Form S-8 No. 333-104219) of Human Genome Sciences, Inc. Amended and Restated 2000 Stock Incentive Plan,
 
  (8)   Registration Statement (Form S-8 No. 333-142713) of Human Genome Sciences, Inc. Employee Stock Purchase Plan and Non-Employee Director Equity Compensation Plan,
 
  (9)   Registration Statement (Form S-8 No. 333-156334) of Human Genome Sciences, Inc. Employee Stock Purchase Plan,
 
  (10)   Registration Statement (Form S-8 No. 333-159003) of Human Genome Sciences, Inc. Amended and Restated Stock Incentive Plan
of our reports dated February 24, 2011, with respect to the consolidated financial statements of Human Genome Sciences, Inc., and the effectiveness of internal control over financial reporting of Human Genome Sciences, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2010.
/s/ Ernst & Young LLP
Baltimore, Maryland
February 24, 2011